Comparison

Degrasyn European Partner

Item no. TMO-T6300-200mg
Manufacturer TargetMol
CASRN 856243-80-6
Amount 200 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Smiles CCC[C@H](NC(=O)C(=C\c1cccc(Br)n1)\C#N)c1ccccc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias WP1130
Shipping Condition Cool pack
Available
Manufacturer - Targets
JAK|||Autophagy|||DUB|||Apoptosis|||Bcr-Abl
Storage Conditions
-20
Molecular Weight
384.27
Description
Degrasyn (WP1130) (WP1130), a specific deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor, also inhibits Bcr/Abl, which is a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).
Pathways
Autophagy|||Tyrosine Kinase/Adaptors|||Chromatin/Epigenetic|||Apoptosis|||JAK/STAT signaling|||DNA Damage/DNA Repair|||Angiogenesis|||Stem Cells|||Ubiquitination|||Cell Cycle/Checkpoint|||Cytoskeletal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close